nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—SLC6A14—mammary gland—breast cancer	0.0222	0.341	CbGeAlD
Valaciclovir—SLC6A14—female reproductive system—breast cancer	0.00917	0.141	CbGeAlD
Valaciclovir—SLC6A14—endocrine gland—breast cancer	0.00776	0.119	CbGeAlD
Valaciclovir—SLC10A2—endocrine gland—breast cancer	0.00505	0.0776	CbGeAlD
Valaciclovir—SLC15A2—mammary gland—breast cancer	0.00349	0.0537	CbGeAlD
Valaciclovir—SLC15A1—epithelium—breast cancer	0.00311	0.0478	CbGeAlD
Valaciclovir—SLC15A1—endometrium—breast cancer	0.00279	0.0429	CbGeAlD
Valaciclovir—SLC15A1—endocrine gland—breast cancer	0.00196	0.0301	CbGeAlD
Valaciclovir—SLC15A2—endometrium—breast cancer	0.00174	0.0268	CbGeAlD
Valaciclovir—SLC15A2—pituitary gland—breast cancer	0.00158	0.0243	CbGeAlD
Valaciclovir—SLC15A2—female reproductive system—breast cancer	0.00145	0.0222	CbGeAlD
Valaciclovir—SLC15A2—adrenal gland—breast cancer	0.00141	0.0217	CbGeAlD
Valaciclovir—SLC15A2—female gonad—breast cancer	0.00132	0.0202	CbGeAlD
Valaciclovir—SLC15A2—endocrine gland—breast cancer	0.00122	0.0188	CbGeAlD
Valaciclovir—SLC15A2—lymph node—breast cancer	0.000846	0.013	CbGeAlD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000433	0.00154	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000433	0.00154	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000428	0.00152	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000428	0.00152	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—MED12—breast cancer	0.000419	0.00149	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000415	0.00147	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CHST9—breast cancer	0.000409	0.00145	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000402	0.00143	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000402	0.00143	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	0.0004	0.00142	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.00039	0.00139	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	0.000389	0.00138	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—COX11—breast cancer	0.000388	0.00138	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	0.000382	0.00136	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000378	0.00134	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ACHE—breast cancer	0.00037	0.00131	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCG2—breast cancer	0.00037	0.00131	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000368	0.00131	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—COX11—breast cancer	0.000359	0.00127	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000359	0.00127	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000357	0.00127	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000357	0.00127	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CDA—breast cancer	0.000355	0.00126	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SHMT1—breast cancer	0.000355	0.00126	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	0.000351	0.00124	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	0.000347	0.00123	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000346	0.00123	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLCO1B1—breast cancer	0.000342	0.00121	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC2A5—breast cancer	0.000342	0.00121	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000339	0.0012	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	0.000334	0.00119	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000333	0.00118	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—COX11—breast cancer	0.000333	0.00118	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—APRT—breast cancer	0.00033	0.00117	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—TFRC—breast cancer	0.00033	0.00117	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000328	0.00116	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000326	0.00116	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—FASN—breast cancer	0.000324	0.00115	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	0.000323	0.00115	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000322	0.00114	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000318	0.00113	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000316	0.00112	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000316	0.00112	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ESRRA—breast cancer	0.00031	0.0011	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ANGPTL4—breast cancer	0.00031	0.0011	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000304	0.00108	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000303	0.00108	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—TFRC—breast cancer	0.000302	0.00107	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000299	0.00106	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000298	0.00106	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000298	0.00106	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000296	0.00105	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—COX11—breast cancer	0.000296	0.00105	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	0.000295	0.00105	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HADHB—breast cancer	0.000294	0.00104	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GPI—breast cancer	0.000294	0.00104	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000293	0.00104	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000293	0.00104	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000293	0.00104	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—NCOA2—breast cancer	0.00029	0.00103	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	0.000281	0.000999	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALDH1A1—breast cancer	0.000281	0.000997	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALDH7A1—breast cancer	0.000281	0.000997	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	0.000277	0.000985	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000277	0.000984	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000272	0.000965	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000271	0.000961	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PHGDH—breast cancer	0.000269	0.000955	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—UMPS—breast cancer	0.000269	0.000955	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ADSL—breast cancer	0.000269	0.000955	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NME1—breast cancer	0.000269	0.000955	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—FHL2—breast cancer	0.000269	0.000955	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000268	0.00095	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000268	0.00095	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000265	0.000943	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LDHB—breast cancer	0.000264	0.000937	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—BRIP1—breast cancer	0.000264	0.000937	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HPSE—breast cancer	0.000264	0.000937	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—TGFB1—breast cancer	0.000261	0.000927	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—PLG—breast cancer	0.000261	0.000926	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000261	0.000925	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000261	0.000925	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—breast cancer	0.00026	0.000924	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000258	0.000916	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000252	0.000895	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTA3—breast cancer	0.00025	0.000888	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ABCC1—breast cancer	0.00025	0.000888	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HMMR—breast cancer	0.00025	0.000888	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000249	0.000885	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000248	0.000882	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000247	0.000877	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—COX11—breast cancer	0.000247	0.000877	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000245	0.000869	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PPARGC1B—breast cancer	0.000242	0.00086	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000241	0.000855	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000239	0.00085	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—PLG—breast cancer	0.000239	0.000847	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	0.000236	0.000838	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	0.000236	0.000838	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000231	0.000821	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000231	0.00082	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000231	0.00082	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000231	0.000819	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTA4—breast cancer	0.000229	0.000812	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CA9—breast cancer	0.000229	0.000812	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000226	0.000802	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	0.000226	0.000802	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000224	0.000796	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	0.000224	0.000794	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTA2—breast cancer	0.000223	0.000792	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GPX2—breast cancer	0.000223	0.000792	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000222	0.000787	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GPX4—breast cancer	0.00022	0.000782	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SULT1A1—breast cancer	0.00022	0.000782	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—HMOX1—breast cancer	0.00022	0.000782	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000217	0.000772	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000217	0.000772	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—IDH1—breast cancer	0.000215	0.000764	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTA1—breast cancer	0.000215	0.000764	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000214	0.000761	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000213	0.000756	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NAT2—breast cancer	0.000213	0.000755	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000211	0.00075	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000206	0.00073	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000205	0.000728	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000196	0.000698	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	0.000192	0.000683	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000191	0.000677	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000187	0.000665	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—MED12—breast cancer	0.000186	0.000662	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—DPYD—breast cancer	0.000186	0.000662	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALDOA—breast cancer	0.000184	0.000652	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000182	0.000647	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NCOA3—breast cancer	0.000178	0.000633	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000178	0.000631	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC2A2—breast cancer	0.000177	0.000628	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	0.000175	0.000622	CbGpPWpGaD
Valaciclovir—Oedema peripheral—Epirubicin—breast cancer	0.000174	0.000266	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—MTR—breast cancer	0.000173	0.000616	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ABCG2—breast cancer	0.000173	0.000616	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CPT1A—breast cancer	0.000173	0.000616	CbGpPWpGaD
Valaciclovir—Haematuria—Doxorubicin—breast cancer	0.000173	0.000265	CcSEcCtD
Valaciclovir—Abdominal pain—Paclitaxel—breast cancer	0.000173	0.000265	CcSEcCtD
Valaciclovir—Body temperature increased—Paclitaxel—breast cancer	0.000173	0.000265	CcSEcCtD
Valaciclovir—Urethral disorder—Epirubicin—breast cancer	0.000173	0.000264	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Doxorubicin—breast cancer	0.000172	0.000263	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000172	0.000609	CbGpPWpGaD
Valaciclovir—Anorexia—Capecitabine—breast cancer	0.000171	0.000262	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000171	0.000608	CbGpPWpGaD
Valaciclovir—Vomiting—Mitoxantrone—breast cancer	0.000171	0.000261	CcSEcCtD
Valaciclovir—Vomiting—Irinotecan—breast cancer	0.000171	0.000261	CcSEcCtD
Valaciclovir—Sinusitis—Doxorubicin—breast cancer	0.00017	0.000261	CcSEcCtD
Valaciclovir—Immune system disorder—Methotrexate—breast cancer	0.00017	0.00026	CcSEcCtD
Valaciclovir—Dizziness—Fluorouracil—breast cancer	0.00017	0.00026	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—HPGDS—breast cancer	0.00017	0.000604	CbGpPWpGaD
Valaciclovir—Mediastinal disorder—Methotrexate—breast cancer	0.00017	0.00026	CcSEcCtD
Valaciclovir—Rash—Mitoxantrone—breast cancer	0.000169	0.000259	CcSEcCtD
Valaciclovir—Rash—Irinotecan—breast cancer	0.000169	0.000259	CcSEcCtD
Valaciclovir—Dermatitis—Mitoxantrone—breast cancer	0.000169	0.000259	CcSEcCtD
Valaciclovir—Dermatitis—Irinotecan—breast cancer	0.000169	0.000259	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000169	0.000259	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—HBA1—breast cancer	0.000169	0.0006	CbGpPWpGaD
Valaciclovir—Chills—Methotrexate—breast cancer	0.000169	0.000259	CcSEcCtD
Valaciclovir—Headache—Mitoxantrone—breast cancer	0.000168	0.000257	CcSEcCtD
Valaciclovir—Headache—Irinotecan—breast cancer	0.000168	0.000257	CcSEcCtD
Valaciclovir—Insomnia—Docetaxel—breast cancer	0.000168	0.000257	CcSEcCtD
Valaciclovir—Paraesthesia—Docetaxel—breast cancer	0.000167	0.000255	CcSEcCtD
Valaciclovir—Erythema multiforme—Epirubicin—breast cancer	0.000167	0.000255	CcSEcCtD
Valaciclovir—Alopecia—Methotrexate—breast cancer	0.000166	0.000255	CcSEcCtD
Valaciclovir—Vomiting—Gemcitabine—breast cancer	0.000166	0.000255	CcSEcCtD
Valaciclovir—Dyspnoea—Docetaxel—breast cancer	0.000165	0.000253	CcSEcCtD
Valaciclovir—Somnolence—Docetaxel—breast cancer	0.000165	0.000253	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ACHE—breast cancer	0.000165	0.000586	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTT1—breast cancer	0.000165	0.000586	CbGpPWpGaD
Valaciclovir—Rash—Gemcitabine—breast cancer	0.000165	0.000252	CcSEcCtD
Valaciclovir—Dermatitis—Gemcitabine—breast cancer	0.000165	0.000252	CcSEcCtD
Valaciclovir—Headache—Gemcitabine—breast cancer	0.000164	0.000251	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000164	0.000251	CcSEcCtD
Valaciclovir—Vomiting—Fluorouracil—breast cancer	0.000163	0.00025	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000163	0.00058	CbGpPWpGaD
Valaciclovir—Rhinitis—Doxorubicin—breast cancer	0.000163	0.00025	CcSEcCtD
Valaciclovir—Dyspepsia—Docetaxel—breast cancer	0.000163	0.00025	CcSEcCtD
Valaciclovir—Hepatitis—Doxorubicin—breast cancer	0.000163	0.00025	CcSEcCtD
Valaciclovir—Insomnia—Capecitabine—breast cancer	0.000163	0.000249	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000162	0.000576	CbGpPWpGaD
Valaciclovir—Rash—Fluorouracil—breast cancer	0.000162	0.000248	CcSEcCtD
Valaciclovir—Dermatitis—Fluorouracil—breast cancer	0.000162	0.000248	CcSEcCtD
Valaciclovir—Pharyngitis—Doxorubicin—breast cancer	0.000162	0.000248	CcSEcCtD
Valaciclovir—Paraesthesia—Capecitabine—breast cancer	0.000161	0.000247	CcSEcCtD
Valaciclovir—Decreased appetite—Docetaxel—breast cancer	0.000161	0.000247	CcSEcCtD
Valaciclovir—Hypersensitivity—Paclitaxel—breast cancer	0.000161	0.000247	CcSEcCtD
Valaciclovir—Headache—Fluorouracil—breast cancer	0.000161	0.000247	CcSEcCtD
Valaciclovir—Urinary tract disorder—Doxorubicin—breast cancer	0.000161	0.000246	CcSEcCtD
Valaciclovir—Oedema peripheral—Doxorubicin—breast cancer	0.000161	0.000246	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Docetaxel—breast cancer	0.00016	0.000245	CcSEcCtD
Valaciclovir—Dyspnoea—Capecitabine—breast cancer	0.00016	0.000245	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCG2—breast cancer	0.00016	0.000569	CbGpPWpGaD
Valaciclovir—Fatigue—Docetaxel—breast cancer	0.00016	0.000245	CcSEcCtD
Valaciclovir—Urethral disorder—Doxorubicin—breast cancer	0.00016	0.000245	CcSEcCtD
Valaciclovir—Nausea—Irinotecan—breast cancer	0.000159	0.000244	CcSEcCtD
Valaciclovir—Nausea—Mitoxantrone—breast cancer	0.000159	0.000244	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000159	0.000565	CbGpPWpGaD
Valaciclovir—Immune system disorder—Epirubicin—breast cancer	0.000159	0.000244	CcSEcCtD
Valaciclovir—Mediastinal disorder—Epirubicin—breast cancer	0.000159	0.000243	CcSEcCtD
Valaciclovir—Constipation—Docetaxel—breast cancer	0.000159	0.000243	CcSEcCtD
Valaciclovir—Pain—Docetaxel—breast cancer	0.000159	0.000243	CcSEcCtD
Valaciclovir—Back pain—Methotrexate—breast cancer	0.000159	0.000243	CcSEcCtD
Valaciclovir—Dyspepsia—Capecitabine—breast cancer	0.000158	0.000242	CcSEcCtD
Valaciclovir—Chills—Epirubicin—breast cancer	0.000158	0.000242	CcSEcCtD
Valaciclovir—Asthenia—Paclitaxel—breast cancer	0.000157	0.00024	CcSEcCtD
Valaciclovir—Decreased appetite—Capecitabine—breast cancer	0.000156	0.000239	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP17A1—breast cancer	0.000156	0.000554	CbGpPWpGaD
Valaciclovir—Alopecia—Epirubicin—breast cancer	0.000156	0.000238	CcSEcCtD
Valaciclovir—Nausea—Gemcitabine—breast cancer	0.000155	0.000238	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Capecitabine—breast cancer	0.000155	0.000237	CcSEcCtD
Valaciclovir—Fatigue—Capecitabine—breast cancer	0.000155	0.000237	CcSEcCtD
Valaciclovir—Pruritus—Paclitaxel—breast cancer	0.000155	0.000237	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ENO1—breast cancer	0.000155	0.000549	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS1—breast cancer	0.000155	0.000549	CbGpPWpGaD
Valaciclovir—Erythema multiforme—Doxorubicin—breast cancer	0.000154	0.000236	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	0.000154	0.000547	CbGpPWpGaD
Valaciclovir—Pain—Capecitabine—breast cancer	0.000154	0.000235	CcSEcCtD
Valaciclovir—Constipation—Capecitabine—breast cancer	0.000154	0.000235	CcSEcCtD
Valaciclovir—Feeling abnormal—Docetaxel—breast cancer	0.000153	0.000234	CcSEcCtD
Valaciclovir—Nausea—Fluorouracil—breast cancer	0.000153	0.000234	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	0.000152	0.00054	CbGpPWpGaD
Valaciclovir—Gastrointestinal pain—Docetaxel—breast cancer	0.000152	0.000232	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000152	0.000539	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP2D6—breast cancer	0.000152	0.000538	CbGpPWpGaD
Valaciclovir—Anaemia—Methotrexate—breast cancer	0.000151	0.000232	CcSEcCtD
Valaciclovir—Flatulence—Epirubicin—breast cancer	0.000151	0.000231	CcSEcCtD
Valaciclovir—Tension—Epirubicin—breast cancer	0.000151	0.00023	CcSEcCtD
Valaciclovir—Diarrhoea—Paclitaxel—breast cancer	0.00015	0.000229	CcSEcCtD
Valaciclovir—Nervousness—Epirubicin—breast cancer	0.000149	0.000228	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—NCOA2—breast cancer	0.000149	0.000528	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000149	0.000528	CbGpPWpGaD
Valaciclovir—Back pain—Epirubicin—breast cancer	0.000148	0.000227	CcSEcCtD
Valaciclovir—Feeling abnormal—Capecitabine—breast cancer	0.000148	0.000227	CcSEcCtD
Valaciclovir—Immune system disorder—Doxorubicin—breast cancer	0.000147	0.000225	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Capecitabine—breast cancer	0.000147	0.000225	CcSEcCtD
Valaciclovir—Mediastinal disorder—Doxorubicin—breast cancer	0.000147	0.000225	CcSEcCtD
Valaciclovir—Body temperature increased—Docetaxel—breast cancer	0.000147	0.000225	CcSEcCtD
Valaciclovir—Abdominal pain—Docetaxel—breast cancer	0.000147	0.000225	CcSEcCtD
Valaciclovir—Leukopenia—Methotrexate—breast cancer	0.000147	0.000225	CcSEcCtD
Valaciclovir—Chills—Doxorubicin—breast cancer	0.000146	0.000224	CcSEcCtD
Valaciclovir—Dizziness—Paclitaxel—breast cancer	0.000145	0.000222	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ALB—breast cancer	0.000145	0.000513	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—FASN—breast cancer	0.000144	0.000512	CbGpPWpGaD
Valaciclovir—Alopecia—Doxorubicin—breast cancer	0.000144	0.000221	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—BCHE—breast cancer	0.000144	0.00051	CbGpPWpGaD
Valaciclovir—Cough—Methotrexate—breast cancer	0.000143	0.000219	CcSEcCtD
Valaciclovir—Urticaria—Capecitabine—breast cancer	0.000143	0.000218	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—TFRC—breast cancer	0.000143	0.000507	CbGpPWpGaD
Valaciclovir—Abdominal pain—Capecitabine—breast cancer	0.000142	0.000217	CcSEcCtD
Valaciclovir—Body temperature increased—Capecitabine—breast cancer	0.000142	0.000217	CcSEcCtD
Valaciclovir—Convulsion—Methotrexate—breast cancer	0.000142	0.000217	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—SLC5A5—breast cancer	0.000142	0.000504	CbGpPWpGaD
Valaciclovir—Anaemia—Epirubicin—breast cancer	0.000142	0.000217	CcSEcCtD
Valaciclovir—Agitation—Epirubicin—breast cancer	0.000141	0.000216	CcSEcCtD
Valaciclovir—Flatulence—Doxorubicin—breast cancer	0.00014	0.000214	CcSEcCtD
Valaciclovir—Arthralgia—Methotrexate—breast cancer	0.00014	0.000214	CcSEcCtD
Valaciclovir—Myalgia—Methotrexate—breast cancer	0.00014	0.000214	CcSEcCtD
Valaciclovir—Chest pain—Methotrexate—breast cancer	0.00014	0.000214	CcSEcCtD
Valaciclovir—Tension—Doxorubicin—breast cancer	0.000139	0.000213	CcSEcCtD
Valaciclovir—Vomiting—Paclitaxel—breast cancer	0.000139	0.000213	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000139	0.000212	CcSEcCtD
Valaciclovir—Rash—Paclitaxel—breast cancer	0.000138	0.000211	CcSEcCtD
Valaciclovir—Dermatitis—Paclitaxel—breast cancer	0.000138	0.000211	CcSEcCtD
Valaciclovir—Nervousness—Doxorubicin—breast cancer	0.000138	0.000211	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000137	0.000488	CbGpPWpGaD
Valaciclovir—Leukopenia—Epirubicin—breast cancer	0.000137	0.00021	CcSEcCtD
Valaciclovir—Back pain—Doxorubicin—breast cancer	0.000137	0.00021	CcSEcCtD
Valaciclovir—Headache—Paclitaxel—breast cancer	0.000137	0.00021	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—NQO1—breast cancer	0.000137	0.000487	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC2A1—breast cancer	0.000137	0.000487	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Docetaxel—breast cancer	0.000137	0.000209	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000135	0.000481	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000135	0.000479	CbGpPWpGaD
Valaciclovir—Confusional state—Methotrexate—breast cancer	0.000135	0.000206	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	0.000134	0.000477	CbGpPWpGaD
Valaciclovir—Cough—Epirubicin—breast cancer	0.000134	0.000205	CcSEcCtD
Valaciclovir—Anaphylactic shock—Methotrexate—breast cancer	0.000134	0.000205	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP3A4—breast cancer	0.000134	0.000475	CbGpPWpGaD
Valaciclovir—Asthenia—Docetaxel—breast cancer	0.000133	0.000204	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	0.000133	0.000472	CbGpPWpGaD
Valaciclovir—Convulsion—Epirubicin—breast cancer	0.000133	0.000203	CcSEcCtD
Valaciclovir—Infection—Methotrexate—breast cancer	0.000133	0.000203	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—TFRC—breast cancer	0.000132	0.00047	CbGpPWpGaD
Valaciclovir—Hypertension—Epirubicin—breast cancer	0.000132	0.000203	CcSEcCtD
Valaciclovir—Hypersensitivity—Capecitabine—breast cancer	0.000132	0.000203	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000132	0.000469	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—breast cancer	0.000132	0.000469	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP1B1—breast cancer	0.000131	0.000467	CbGpPWpGaD
Valaciclovir—Pruritus—Docetaxel—breast cancer	0.000131	0.000201	CcSEcCtD
Valaciclovir—Nervous system disorder—Methotrexate—breast cancer	0.000131	0.000201	CcSEcCtD
Valaciclovir—Anaemia—Doxorubicin—breast cancer	0.000131	0.000201	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000131	0.000465	CbGpPWpGaD
Valaciclovir—Thrombocytopenia—Methotrexate—breast cancer	0.000131	0.0002	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—RAF1—breast cancer	0.000131	0.000464	CbGpPWpGaD
Valaciclovir—Myalgia—Epirubicin—breast cancer	0.000131	0.0002	CcSEcCtD
Valaciclovir—Arthralgia—Epirubicin—breast cancer	0.000131	0.0002	CcSEcCtD
Valaciclovir—Chest pain—Epirubicin—breast cancer	0.000131	0.0002	CcSEcCtD
Valaciclovir—Agitation—Doxorubicin—breast cancer	0.00013	0.0002	CcSEcCtD
Valaciclovir—Nausea—Paclitaxel—breast cancer	0.00013	0.000199	CcSEcCtD
Valaciclovir—Skin disorder—Methotrexate—breast cancer	0.00013	0.000199	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.00013	0.000198	CcSEcCtD
Valaciclovir—Asthenia—Capecitabine—breast cancer	0.000129	0.000197	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—HSP90AA1—breast cancer	0.000129	0.000458	CbGpPWpGaD
Valaciclovir—Dry mouth—Epirubicin—breast cancer	0.000128	0.000195	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000128	0.000453	CbGpPWpGaD
Valaciclovir—Anorexia—Methotrexate—breast cancer	0.000128	0.000195	CcSEcCtD
Valaciclovir—Pruritus—Capecitabine—breast cancer	0.000127	0.000195	CcSEcCtD
Valaciclovir—Leukopenia—Doxorubicin—breast cancer	0.000127	0.000194	CcSEcCtD
Valaciclovir—Diarrhoea—Docetaxel—breast cancer	0.000127	0.000194	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000127	0.000449	CbGpPWpGaD
Valaciclovir—Confusional state—Epirubicin—breast cancer	0.000126	0.000193	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—NCOA1—breast cancer	0.000125	0.000445	CbGpPWpGaD
Valaciclovir—Anaphylactic shock—Epirubicin—breast cancer	0.000125	0.000192	CcSEcCtD
Valaciclovir—Oedema—Epirubicin—breast cancer	0.000125	0.000192	CcSEcCtD
Valaciclovir—Infection—Epirubicin—breast cancer	0.000124	0.00019	CcSEcCtD
Valaciclovir—Cough—Doxorubicin—breast cancer	0.000124	0.00019	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—STK11—breast cancer	0.000124	0.000439	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP19A1—breast cancer	0.000124	0.000439	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—breast cancer	0.000123	0.000437	CbGpPWpGaD
Valaciclovir—Convulsion—Doxorubicin—breast cancer	0.000123	0.000188	CcSEcCtD
Valaciclovir—Diarrhoea—Capecitabine—breast cancer	0.000123	0.000188	CcSEcCtD
Valaciclovir—Nervous system disorder—Epirubicin—breast cancer	0.000123	0.000188	CcSEcCtD
Valaciclovir—Dizziness—Docetaxel—breast cancer	0.000123	0.000188	CcSEcCtD
Valaciclovir—Thrombocytopenia—Epirubicin—breast cancer	0.000123	0.000188	CcSEcCtD
Valaciclovir—Hypertension—Doxorubicin—breast cancer	0.000123	0.000188	CcSEcCtD
Valaciclovir—Tachycardia—Epirubicin—breast cancer	0.000122	0.000187	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000122	0.000187	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000122	0.000432	CbGpPWpGaD
Valaciclovir—Skin disorder—Epirubicin—breast cancer	0.000122	0.000186	CcSEcCtD
Valaciclovir—Insomnia—Methotrexate—breast cancer	0.000121	0.000185	CcSEcCtD
Valaciclovir—Chest pain—Doxorubicin—breast cancer	0.000121	0.000185	CcSEcCtD
Valaciclovir—Myalgia—Doxorubicin—breast cancer	0.000121	0.000185	CcSEcCtD
Valaciclovir—Arthralgia—Doxorubicin—breast cancer	0.000121	0.000185	CcSEcCtD
Valaciclovir—Paraesthesia—Methotrexate—breast cancer	0.00012	0.000184	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.00012	0.000184	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—RAF1—breast cancer	0.00012	0.000424	CbGpPWpGaD
Valaciclovir—Anorexia—Epirubicin—breast cancer	0.000119	0.000183	CcSEcCtD
Valaciclovir—Dyspnoea—Methotrexate—breast cancer	0.000119	0.000183	CcSEcCtD
Valaciclovir—Somnolence—Methotrexate—breast cancer	0.000119	0.000182	CcSEcCtD
Valaciclovir—Dizziness—Capecitabine—breast cancer	0.000119	0.000182	CcSEcCtD
Valaciclovir—Dry mouth—Doxorubicin—breast cancer	0.000118	0.000181	CcSEcCtD
Valaciclovir—Vomiting—Docetaxel—breast cancer	0.000118	0.000181	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—TFRC—breast cancer	0.000118	0.000418	CbGpPWpGaD
Valaciclovir—Dyspepsia—Methotrexate—breast cancer	0.000118	0.00018	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000117	0.000417	CbGpPWpGaD
Valaciclovir—Rash—Docetaxel—breast cancer	0.000117	0.000179	CcSEcCtD
Valaciclovir—Dermatitis—Docetaxel—breast cancer	0.000117	0.000179	CcSEcCtD
Valaciclovir—Confusional state—Doxorubicin—breast cancer	0.000117	0.000179	CcSEcCtD
Valaciclovir—Decreased appetite—Methotrexate—breast cancer	0.000116	0.000178	CcSEcCtD
Valaciclovir—Headache—Docetaxel—breast cancer	0.000116	0.000178	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	0.000116	0.000412	CbGpPWpGaD
Valaciclovir—Anaphylactic shock—Doxorubicin—breast cancer	0.000116	0.000177	CcSEcCtD
Valaciclovir—Oedema—Doxorubicin—breast cancer	0.000116	0.000177	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000116	0.000411	CbGpPWpGaD
Valaciclovir—Gastrointestinal disorder—Methotrexate—breast cancer	0.000115	0.000177	CcSEcCtD
Valaciclovir—Fatigue—Methotrexate—breast cancer	0.000115	0.000177	CcSEcCtD
Valaciclovir—Infection—Doxorubicin—breast cancer	0.000115	0.000176	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—COMT—breast cancer	0.000115	0.000408	CbGpPWpGaD
Valaciclovir—Pain—Methotrexate—breast cancer	0.000114	0.000175	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GSTP1—breast cancer	0.000114	0.000406	CbGpPWpGaD
Valaciclovir—Vomiting—Capecitabine—breast cancer	0.000114	0.000175	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—breast cancer	0.000114	0.000405	CbGpPWpGaD
Valaciclovir—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000114	0.000175	CcSEcCtD
Valaciclovir—Nervous system disorder—Doxorubicin—breast cancer	0.000114	0.000174	CcSEcCtD
Valaciclovir—Thrombocytopenia—Doxorubicin—breast cancer	0.000113	0.000174	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000113	0.000403	CbGpPWpGaD
Valaciclovir—Rash—Capecitabine—breast cancer	0.000113	0.000173	CcSEcCtD
Valaciclovir—Insomnia—Epirubicin—breast cancer	0.000113	0.000173	CcSEcCtD
Valaciclovir—Dermatitis—Capecitabine—breast cancer	0.000113	0.000173	CcSEcCtD
Valaciclovir—Tachycardia—Doxorubicin—breast cancer	0.000113	0.000173	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—PLG—breast cancer	0.000113	0.000401	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HMOX1—breast cancer	0.000113	0.0004	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000113	0.0004	CbGpPWpGaD
Valaciclovir—Headache—Capecitabine—breast cancer	0.000113	0.000172	CcSEcCtD
Valaciclovir—Skin disorder—Doxorubicin—breast cancer	0.000113	0.000172	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ITPR1—breast cancer	0.000112	0.000399	CbGpPWpGaD
Valaciclovir—Paraesthesia—Epirubicin—breast cancer	0.000112	0.000172	CcSEcCtD
Valaciclovir—Dyspnoea—Epirubicin—breast cancer	0.000112	0.000171	CcSEcCtD
Valaciclovir—Somnolence—Epirubicin—breast cancer	0.000111	0.00017	CcSEcCtD
Valaciclovir—Anorexia—Doxorubicin—breast cancer	0.00011	0.000169	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCG2—breast cancer	0.00011	0.000392	CbGpPWpGaD
Valaciclovir—Nausea—Docetaxel—breast cancer	0.00011	0.000169	CcSEcCtD
Valaciclovir—Feeling abnormal—Methotrexate—breast cancer	0.00011	0.000169	CcSEcCtD
Valaciclovir—Dyspepsia—Epirubicin—breast cancer	0.00011	0.000169	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Methotrexate—breast cancer	0.000109	0.000167	CcSEcCtD
Valaciclovir—Decreased appetite—Epirubicin—breast cancer	0.000109	0.000167	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ABCB1—breast cancer	0.000108	0.000384	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000108	0.000384	CbGpPWpGaD
Valaciclovir—Gastrointestinal disorder—Epirubicin—breast cancer	0.000108	0.000165	CcSEcCtD
Valaciclovir—Fatigue—Epirubicin—breast cancer	0.000108	0.000165	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000107	0.000382	CbGpPWpGaD
Valaciclovir—Pain—Epirubicin—breast cancer	0.000107	0.000164	CcSEcCtD
Valaciclovir—Constipation—Epirubicin—breast cancer	0.000107	0.000164	CcSEcCtD
Valaciclovir—Nausea—Capecitabine—breast cancer	0.000107	0.000163	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—TYMS—breast cancer	0.000106	0.000377	CbGpPWpGaD
Valaciclovir—Urticaria—Methotrexate—breast cancer	0.000106	0.000163	CcSEcCtD
Valaciclovir—Body temperature increased—Methotrexate—breast cancer	0.000106	0.000162	CcSEcCtD
Valaciclovir—Abdominal pain—Methotrexate—breast cancer	0.000106	0.000162	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000106	0.000162	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GSTM1—breast cancer	0.000105	0.000373	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PLA2G4A—breast cancer	0.000105	0.000373	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NCOR1—breast cancer	0.000105	0.000373	CbGpPWpGaD
Valaciclovir—Insomnia—Doxorubicin—breast cancer	0.000105	0.00016	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—PLG—breast cancer	0.000105	0.000372	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000104	0.000371	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000104	0.00037	CbGpPWpGaD
Valaciclovir—Paraesthesia—Doxorubicin—breast cancer	0.000104	0.000159	CcSEcCtD
Valaciclovir—Dyspnoea—Doxorubicin—breast cancer	0.000103	0.000158	CcSEcCtD
Valaciclovir—Feeling abnormal—Epirubicin—breast cancer	0.000103	0.000158	CcSEcCtD
Valaciclovir—Somnolence—Doxorubicin—breast cancer	0.000103	0.000158	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Epirubicin—breast cancer	0.000102	0.000157	CcSEcCtD
Valaciclovir—Dyspepsia—Doxorubicin—breast cancer	0.000102	0.000156	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—breast cancer	0.000102	0.000361	CbGpPWpGaD
Valaciclovir—Decreased appetite—Doxorubicin—breast cancer	0.000101	0.000154	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GPX1—breast cancer	0.000101	0.000357	CbGpPWpGaD
Valaciclovir—Gastrointestinal disorder—Doxorubicin—breast cancer	0.0001	0.000153	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCB1—breast cancer	9.99e-05	0.000355	CbGpPWpGaD
Valaciclovir—Fatigue—Doxorubicin—breast cancer	9.99e-05	0.000153	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CYP1A1—breast cancer	9.96e-05	0.000354	CbGpPWpGaD
Valaciclovir—Urticaria—Epirubicin—breast cancer	9.94e-05	0.000152	CcSEcCtD
Valaciclovir—Constipation—Doxorubicin—breast cancer	9.9e-05	0.000152	CcSEcCtD
Valaciclovir—Pain—Doxorubicin—breast cancer	9.9e-05	0.000152	CcSEcCtD
Valaciclovir—Abdominal pain—Epirubicin—breast cancer	9.9e-05	0.000151	CcSEcCtD
Valaciclovir—Body temperature increased—Epirubicin—breast cancer	9.9e-05	0.000151	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ERCC2—breast cancer	9.88e-05	0.000351	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Methotrexate—breast cancer	9.85e-05	0.000151	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—TFRC—breast cancer	9.83e-05	0.000349	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—HMOX1—breast cancer	9.66e-05	0.000343	CbGpPWpGaD
Valaciclovir—Asthenia—Methotrexate—breast cancer	9.6e-05	0.000147	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—NCOA1—breast cancer	9.56e-05	0.000339	CbGpPWpGaD
Valaciclovir—Feeling abnormal—Doxorubicin—breast cancer	9.54e-05	0.000146	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Doxorubicin—breast cancer	9.47e-05	0.000145	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—NCOA2—breast cancer	9.46e-05	0.000336	CbGpPWpGaD
Valaciclovir—Pruritus—Methotrexate—breast cancer	9.46e-05	0.000145	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—PLG—breast cancer	9.31e-05	0.000331	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—MTHFR—breast cancer	9.28e-05	0.00033	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCB1—breast cancer	9.27e-05	0.000329	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Epirubicin—breast cancer	9.22e-05	0.000141	CcSEcCtD
Valaciclovir—Urticaria—Doxorubicin—breast cancer	9.2e-05	0.000141	CcSEcCtD
Valaciclovir—Abdominal pain—Doxorubicin—breast cancer	9.16e-05	0.00014	CcSEcCtD
Valaciclovir—Body temperature increased—Doxorubicin—breast cancer	9.16e-05	0.00014	CcSEcCtD
Valaciclovir—Diarrhoea—Methotrexate—breast cancer	9.15e-05	0.00014	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—breast cancer	9.03e-05	0.000321	CbGpPWpGaD
Valaciclovir—Asthenia—Epirubicin—breast cancer	8.98e-05	0.000137	CcSEcCtD
Valaciclovir—Pruritus—Epirubicin—breast cancer	8.86e-05	0.000136	CcSEcCtD
Valaciclovir—Dizziness—Methotrexate—breast cancer	8.85e-05	0.000135	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A1—breast cancer	8.72e-05	0.00031	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—HMOX1—breast cancer	8.59e-05	0.000305	CbGpPWpGaD
Valaciclovir—Diarrhoea—Epirubicin—breast cancer	8.56e-05	0.000131	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CAV1—breast cancer	8.56e-05	0.000304	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Doxorubicin—breast cancer	8.53e-05	0.000131	CcSEcCtD
Valaciclovir—Vomiting—Methotrexate—breast cancer	8.5e-05	0.00013	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—breast cancer	8.48e-05	0.000301	CbGpPWpGaD
Valaciclovir—Rash—Methotrexate—breast cancer	8.43e-05	0.000129	CcSEcCtD
Valaciclovir—Dermatitis—Methotrexate—breast cancer	8.43e-05	0.000129	CcSEcCtD
Valaciclovir—Headache—Methotrexate—breast cancer	8.38e-05	0.000128	CcSEcCtD
Valaciclovir—Asthenia—Doxorubicin—breast cancer	8.31e-05	0.000127	CcSEcCtD
Valaciclovir—Dizziness—Epirubicin—breast cancer	8.28e-05	0.000127	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—breast cancer	8.25e-05	0.000293	CbGpPWpGaD
Valaciclovir—Pruritus—Doxorubicin—breast cancer	8.19e-05	0.000125	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.18e-05	0.00029	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—NCOA1—breast cancer	7.98e-05	0.000283	CbGpPWpGaD
Valaciclovir—Vomiting—Epirubicin—breast cancer	7.96e-05	0.000122	CcSEcCtD
Valaciclovir—Nausea—Methotrexate—breast cancer	7.95e-05	0.000122	CcSEcCtD
Valaciclovir—Diarrhoea—Doxorubicin—breast cancer	7.92e-05	0.000121	CcSEcCtD
Valaciclovir—Rash—Epirubicin—breast cancer	7.89e-05	0.000121	CcSEcCtD
Valaciclovir—Dermatitis—Epirubicin—breast cancer	7.89e-05	0.000121	CcSEcCtD
Valaciclovir—Headache—Epirubicin—breast cancer	7.84e-05	0.00012	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—PIK3CG—breast cancer	7.8e-05	0.000277	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—PLG—breast cancer	7.77e-05	0.000276	CbGpPWpGaD
Valaciclovir—Dizziness—Doxorubicin—breast cancer	7.66e-05	0.000117	CcSEcCtD
Valaciclovir—Nausea—Epirubicin—breast cancer	7.44e-05	0.000114	CcSEcCtD
Valaciclovir—Vomiting—Doxorubicin—breast cancer	7.36e-05	0.000113	CcSEcCtD
Valaciclovir—Rash—Doxorubicin—breast cancer	7.3e-05	0.000112	CcSEcCtD
Valaciclovir—Dermatitis—Doxorubicin—breast cancer	7.3e-05	0.000112	CcSEcCtD
Valaciclovir—Headache—Doxorubicin—breast cancer	7.26e-05	0.000111	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—breast cancer	7.17e-05	0.000255	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—breast cancer	6.88e-05	0.000244	CbGpPWpGaD
Valaciclovir—Nausea—Doxorubicin—breast cancer	6.88e-05	0.000105	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—PIK3CD—breast cancer	6.86e-05	0.000243	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALB—breast cancer	6.77e-05	0.00024	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NOS3—breast cancer	6.47e-05	0.00023	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—breast cancer	6.25e-05	0.000222	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CB—breast cancer	5.98e-05	0.000212	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS2—breast cancer	5.92e-05	0.00021	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—breast cancer	5.8e-05	0.000206	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—RAF1—breast cancer	5.65e-05	0.000201	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—RAF1—breast cancer	5.25e-05	0.000186	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTEN—breast cancer	5.16e-05	0.000183	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—breast cancer	5.16e-05	0.000183	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—RAF1—breast cancer	4.67e-05	0.000166	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—breast cancer	4.31e-05	0.000153	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	3.89e-05	0.000138	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CA—breast cancer	3.64e-05	0.000129	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AKT1—breast cancer	2.98e-05	0.000106	CbGpPWpGaD
